The landscape of targeted therapies for cholangiocarcinoma: Current status and emerging targets

The landscape of targeted therapies for cholangiocarcinoma: Current status and emerging targets

10.18632/oncotarget.8775

Saved in:

書目詳細資料
Main Authors:	Chong, D.Q, Zhu, A.X
其他作者:	DUKE-NUS MEDICAL SCHOOL
格式:	Review
出版:	Impact Journals LLC 2020
主題:	B Raf kinase bevacizumab biological marker bortezomib cabozantinib capecitabine cediranib ceritinib cetuximab cisplatin dasatinib epidermal growth factor receptor erlotinib fibroblast growth factor receptor 2 gemcitabine hybrid protein irinotecan isocitrate dehydrogenase K ras protein lapatinib oxaliplatin panitumumab ponatinib protein p53 selumetinib sorafenib sunitinib tivantinib unindexed drug vandetanib FGFR2 protein, human MET protein, human programmed death 1 receptor scatter factor receptor vasculotropin receptor advanced cancer bile duct carcinoma biliary tract cancer cancer combination chemotherapy cancer incidence cancer patient cancer prognosis cancer survival drug targeting epithelium cell exome gene mutation hepatobiliary system human liver cancer liver cell carcinoma metastasis molecularly targeted therapy next generation sequencing nonhuman Review somatic mutation antagonists and inhibitors bile duct tumor gene fusion genetics mutation Bile Duct Neoplasms Cholangiocarcinoma Gene Fusion Humans Isocitrate Dehydrogenase Molecular Targeted Therapy Mutation Programmed Cell Death 1 Receptor Proto-Oncogene Proteins c-met Receptor, Epidermal Growth Factor Receptor, Fibroblast Growth Factor, Type 2 Receptors, Vascular Endothelial Growth Factor
在線閱讀:	https://scholarbank.nus.edu.sg/handle/10635/180389
標簽:	添加標簽沒有標簽, 成為第一個標記此記錄!
機構:	National University of Singapore

相似書籍

Andrographolide regulates epidermal growth factor receptor and transferrin receptor trafficking in epidermoid carcinoma (A-431) cells: Research paper
由: Tan, Y., et al.
出版: (2011)

Phosphoproteomics, oncogenic signaling and cancer research
由: Chong, P.-K., et al.
出版: (2014)

REGULATION OF RECEPTOR TRAFFICKING IN MAMMALIAN CELLS BY ANDROGRAPHOLIDE
由: TAN YINGROU
出版: (2013)

SNX3-dependent regulation of epidermal growth factor receptor (EGFR) trafficking and degradation by aspirin in epidermoid carcinoma (A-431) cells
由: Chiow, K.H., et al.
出版: (2014)

Syntaxin 9 is enriched in skin hair follicle epithelium and interacts with the epidermal growth factor receptor
由: Wang, Y., et al.
出版: (2011)

Grb2 regulates Stat3 activation negatively in epidermal growth factor signalling
由: Zhang, T., et al.
出版: (2013)

Proteomics of breast cancer: Enhanced expression of cytokeratin 19 in human epidermal growth factor receptor type 2 positive breast tumors
由: Zhang, D.-H., et al.
出版: (2011)

Proteomics of breast cancer: Enhanced expression of cytokeratin 19 in human epidermal growth factor receptor type 2 positive breast tumors
由: Zhang, D.-H.|, et al.
出版: (2012)

Mutations in the epidermal growth factor receptor (EGFR) gene in triple negative breast cancer: Possible implications for targeted therapy
由: Teng, Y.H.-F, et al.
出版: (2020)

Meta-analysis of first-line therapies in advanced non-small-cell lung cancer harboring EGFR-activating mutations
由: Haaland, B., et al.
出版: (2016)

Prognostic significance of expression of cyclooxygenase-2, vascular endothelial growth factor, and epidermal growth factor receptor in nasopharyngeal carcinoma
由: Pan, J., et al.
出版: (2016)

Contribution of EGFR and ErbB-3 heterodimerization to the EGFR mutation-induced gefitinib- and erlotinib-resistance in non-small-cell lung carcinoma treatments
由: Wang D.D., et al.
出版: (2019)

Modulation of EGF receptor by tumor necrosis factor-α in human hepatocellular carcinoma HepG2 cells
由: Wang, D., et al.
出版: (2013)

Incidence of cholangiocarcinoma and prevalence of opisthorchis viverrini infestation in Songkhla province, Southern Thailand
由: Seesai Yeesoonsang
出版: (2019)

Release of HER2 repression of trefoil factor 3 (TFF3) expression mediates trastuzumab resistance in HER2+/ER+ mammary carcinoma
由: Chong, Q.-Y, et al.
出版: (2020)

Identification of potentially useful combinations of epidermal growth factor receptor tyrosine kinase antagonists with conventional cytotoxic agents using median effect analysis
由: Budman, D.R., et al.
出版: (2014)

INVESTIGATION OF EPIDERMAL GROWTH FACTOR RECEPTOR IN LIVE CELLS BY VARIOUS FLUORESCENCE CROSS-CORRELATION SPECTROSCOPY MODALITIES
由: SIBEL YAVAS
出版: (2017)

Expression and clinical significance of c-Met in advanced esophageal squamous cell carcinoma
由: Xu, Y, et al.
出版: (2020)

Transmodulation of EGF receptor by interferon-γ in human hepatocellular carcinoma HepG2 cells
由: Wang, D., et al.
出版: (2013)

Inhibition of epidermal growth factor receptor tyrosine kinase by chalcone derivatives
由: Yang, E.B., et al.
出版: (2014)

Frequent loss of RUNX3 gene expression in human bile duct and pancreatic cancer cell lines
由: Wada, M., et al.
出版: (2011)

Phase 2 trial of linifanib (ABT-869) in patients with unresectable or metastatic hepatocellular carcinoma
由: Toh, H.C., et al.
出版: (2014)

Bile cytology: Diagnostic role in the management of biliary obstruction
由: Nilsson, B., et al.
出版: (2012)

PEG5000-grafted-Chitosan/DNA complexes for liver targeted gene delivery
由: JIANG XUAN
出版: (2010)

EGFR Mutant Structural Database: Computationally predicted 3D structures and the corresponding binding free energies with gefitinib and erlotinib
由: Ma, L, et al.
出版: (2020)

The study of interactions of transmembrane receptors and intracellular signaling proteins in live cells by fluorescence correlation and cross-correlation spectroscopy
由: LIU PING
出版: (2011)

Erlotinib at a dose of 25 mg daily for non-small cell lung cancers with EGFR mutations
由: Yeo, W.-L., et al.
出版: (2011)

Updating the Wnt pathways
由: Yu, J, et al.
出版: (2020)

Differential expression patterns of egf, egfr, and erbb4 in nasal polyp epithelium
由: Duan C., et al.
出版: (2020)

The response of human gingival fibroblasts to toll-like receptor ligands
由: Pattanin Montreekachon
出版: (2008)

FGF2 is overexpressed in asthma and promotes airway inflammation through the FGFR/MAPK/NF-κB pathway in airway epithelial cells
由: Tan, YY, et al.
出版: (2022)

Combinatorial treatment of photothermal therapy using gold nanoshells with conventional photodynamic therapy to improve treatment efficacy: An in vitro study
由: Kah, J.C.Y., et al.
出版: (2014)

Chitosan-g-PEG/DNA complexes deliver gene to the rat liver via intrabiliary and intraportal infusions
由: Jiang, X., et al.
出版: (2014)

In silico drug discovery for potential epidermal growth factor receptor agonists
由: Han, Hao
出版: (2024)

Cost-effectiveness of epidermal growth factor receptor mutation testing and first-line treatment with gefitinib for patients with advanced adenocarcinoma of the lung
由: De Lima Lopes Jr., G., et al.
出版: (2016)

Structure of the C-terminal domain of TRADD reveals a novel fold in the death domain superfamily
由: Zhang, N, et al.
出版: (2020)

Detection of serum matrix metalloproteinase (MMP)-7 for differentiating cholangiocarcinoma from benign biliary tract disease patients : evalution of diagnostic accuracy
由: Kawin Leelawat
出版: (2011)

Predictive factors for synchronous common bile duct stones in patients with cholelithiasis
由: Alponat, A., et al.
出版: (2011)

9q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: Evidence from the Breast Cancer Association Consortium
由: Warren, H, et al.
出版: (2020)

Electroporation of NKG2D RNA CAR Improves V?9V?2 T Cell Responses against Human Solid Tumor Xenografts
由: Ang, W.X., et al.
出版: (2021)